EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the ability of human peripheral blood monocytes and in vitro monocyte derived macrophages to produce super oxide anion studies with cells from normals and patients with chronic granulomatous disease






Journal of the Reticuloendothelial Society 31(3): 261-266

Differences in the ability of human peripheral blood monocytes and in vitro monocyte derived macrophages to produce super oxide anion studies with cells from normals and patients with chronic granulomatous disease

Monocytes from normals and patients with chronic granulomatous disease (CGD) and macrophages derived from these monocytes were examined for their ability to produce superoxide anion O2. The response of normal monocytes increased 2.5 to 3-fold by day 3-5 in culture and then decreased, at a time when other cellular functions continued to increase. CGD monocytes never developed the capacity to release.

(PDF 0-2 workdays service: $29.90)

Accession: 005151050

PMID: 6281432



Related references

Polymorphonuclear cells from human peripheral blood, but not lymphocytes, monocytes, or monocyte-derived macrophages, cause the in vitro hydrolysis of apolipoprotein A-II of serum high density lipoproteins. Transactions of the Association of American Physicians 95: 86-93, 1982

Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro. Immunology 49(1): 169-174, 1983

Human peripheral blood monocyte derived macrophages produce hemolytically active complement c 3 in vitro. Immunology 49(1): 169-174, 1983

Effect of c reactive protein on super oxide anion formation by peripheral blood monocytes of normal individuals and leprosy patients in vitro. Federation Proceedings 43(3): ABSTRACT 591, 1984

Monocyte super oxide anion production in rheumatoid arthritis preliminary evidence for enhanced rates of super oxide anion production by monocytes from patients receiving penicillamine sodium auro thio malate and cortico steroids. Annals of the Rheumatic Diseases 43(1): 28-33, 1984

Quantitation of super oxide production in human polymorphonuclear leukocytes from normals and 3 types of chronic granulomatous disease. Biochemical & Biophysical Research Communications 90(1): 214-219, 1979

HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals. International Journal Of Clinical & Laboratory Research. 27(2): 111-117, 1997

Nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS (Hagerstown) 15(8): 945-955, 2001

Human peripheral blood monocyte derived macrophages produce hemolytically active complement c 3. Federation Proceedings 41(3): ABSTRACT 2696, 1982

Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells. Cancer Immunology Immunotherapy 19(1): 62-67, 1985